Clinical Trial

I-SPY COVID: testing novel drugs or drug combinations to treat COVID-19

Study Status:

Not Yet Recruiting

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The objective of this study is to identify agents that will result in substantial improvements to the clinical condition of participants with COVID-19.

Information:

Principal Investigator	Praveen Vijhani, MD
Sponsor	Quantum Leap Healthcare Collaborative
Type of Trial	Interventional

Contact Us For More Info Or To Apply

5323 S. McColl Rd., Edinburg, TX 78539

[email protected]

(956) 362-2390

Clinical Trial

I-SPY COVID: testing novel drugs or drug combinations to treat COVID-19

Study Status:

Study Purpose:

Information:

Useful Links

For Research Participants

About Us

News & Views